FDA Approves Neuropace's Implantable Neurostimulator for Treatment-Resistant Epilepsy

Medindia Health News Medindia largest health website in india. // via fulltextrssfeed.com

Want to learn how to design a logo? This beginner logo design course will take you step by step through the process from start to finish. From our sponsors

FDA Approves Neuropace's Implantable Neurostimulator for Treatment-Resistant Epilepsy Nov 15th 2013, 15:05 Known as the RNS Stimulator, the device can be implanted within the skull under the scalp and is connected to electrodes that are placed where the seizures are suspected to originate within the brain. Neuropace conducted a randomized trial involving 191 patients over a period of three-months after which it found that the device was able to cut down the number of seizures by 38 percent per month. "The neurostimulator detects abnormal electrical activity in the brain and responds by delivering electrical stimulation intended to normalize brain activity before the patient experiences seizure symptoms", the director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, Christy Foreman said. Source: Medindia

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions